Septal-preoptic unit responses to microelectrophoresis of cholecystokinin, gastrin, vasoactive intestinal peptide and secretin in the rat

Histochemistry in rat brain and spinal cord with an antibody directed at the cholecystokininA receptor

Various neurobiological evidence indicates that A-subtype cholecystokinin (CCKA) receptors are widely distributed through the mammalian neuroaxis despite the sparse localization found by receptor autoradiography. To address this paradox, immunohistochemistry has been performed in rat brain and spinal cord using an antibody directed at a portion of the amino terminal sequence of the CCKA receptor. Immunoreactivity, visualised using diaminobenzidine, was widely and topographically distributed being most concentrated in medulla and spinal cord. Many forebrain areas contained specifically labelled neurones, notably the nucleus accumbens, septum, stria terminalis, habenula, substantia nigra, ventral tegmental area and lateral geniculate nucleus. In medulla, heavily labelled perikarya were found in parabrachial and trigeminal nuclei, while in spinal cord immunoreactivity was localized in dorsal horn. Localization of immunoreactivity was consistent with the reported distribution of CCKA receptor-mediated mechanisms. Our observations represent the first attempt to describe the localization of the CCKA receptor in brain using immunohistochemistry and support its wide functional involvement in the central nervous system.

Cholecystokinin-induced activity changes of dorsal lateral geniculate neurons in rats

The effects of iontophoretically applied cholecystokinin fragments and cholecystokinin antagonists on neurons of the dorsal lateral geniculate nucleus were investigated with extracellular recordings in rats anesthetized with urethane. The peptide cholecystokinin-8S, which has affinity for both cholecystokinin-A and -B receptors, altered the baseline firing as well as the responses to visual stimuli of about one half of the investigated neurons (90 out of 190). Excitatory effects predominated (P < 0.01, Wilcoxon test), although inhibitory effects were also observed. The effects of cholecystokinin-8S were dose-dependent. Neurons sensitive to cholecystokinin-8S could be found in all regions of the dorsal lateral geniculate nucleus, but they differed in their susceptibility to cholecystokinin in relation to their location. The B-agonist, BOC-cholecystokinin-4, also changed the baseline firing as well as the light-evoked activity of dorsal lateral geniculate nucleus neurons. The effects were either excitatory or inhibitory. Changes induced by cholecystokinin-8S could be effectively blocked by the cholecystokinin-B antagonist, CAM 1028 (19 out of 22 cholecystokinin-sensitive neurons tested). The cholecystokinin-A antagonist, Ge 410, blocked cholecystokinin-induced effects in 10 out of 16 neurons. These results indicate that the modulation of geniculate cell firing by cholecystokinin is mediated by both A-and B-receptor types.

Preoptic unit responses to microelectrophoresis of neurotensin and its antiserum in female rats

Abstract We and other investigators have demonstrated the stimulation of luteinizing hormone secretion following the microinjection of neurotensin (NT) into the medial preoptic area in female rats. The present study electrophysiologically examined the action of the peptide in the same brain region. Microelectrophoresis of NT produced either excitation or inhibition in 24% of the medial preoptic neurons tested in oestrogen-primed and unprimed ovariectomized animals. Effective blockade of NT-induced excitatory and inhibitor unit responses by means of the simultaneous application of an antiserum to NT (anti-NT) indicated that they were produced by specific actions of the peptide. In addition, anti-NT by itself altered the spontaneous firing rate in some NT-responsive cells. These findings are in accord with the hypothesis that the preoptic area is a site of the action of NT in the female rat.

Brain neuropeptides: actions on central cardiovascular control mechanisms

The many peptides we have not considered (e.g. gastrin, motilin, FMRFamide, carnosine, litorin, dermorphin, casomorphin, eledoisin, prolactin, growth hormone, neuromedin U, proctolin, etc.) were omitted due to lack of information as far as any putative central cardiovascular effects are concerned. However, even for some of these peptide pariahs intriguing snippets of information are available now (e.g. ref. 85), although as we write, the list of possible candidates for investigation grows longer. On an optimistic note, it is becoming clear that many brain neuropeptides may have important effects on cardiovascular regulation. It seems feasible that 'chemically coded' pathways in the brain might be the neuroanatomical correlate of a 'viscerotopic' organization of cardiovascular control mechanisms, whereby the activity of the heart and flows through vascular beds are individually controlled, but in an integrated fashion, utilizing particular combinations of neurotransmitters and neuropeptides within the brain. Such possibilities can only be investigated, properly, by measurement of changes in cardiac output and regional haemodynamics in response to appropriate interventions, in conscious, unrestrained animals.

Neuropeptides and septo-hippocampal neurons: electrophysiological effects and distributions of immunoreactivity

The septo-hippocampal neurons (SHNs), located in the medial septum, project to the hippocampal formation. The population of SHNs, as shown by single unit recordings in urethane-anesthetized rats, is heterogeneous, both in terms of patterns of spontaneous activity (a significant proportion of the SHNs display a characteristic rhythmically bursting activity at about 4 Hz) and of conduction velocity. Their average rate of spontaneous discharge is quite high (20 impulses per second). They are excited by the iontophoretic application of acetylcholine and various cholinergic agonists. They are also excited by some peptides such as substance P and TRH. Parallel studies in aged animals show that the physiological properties of the SHNs are altered, while their pharmacological properties seem to be unchanged. Immunohistochemical investigations using antibodies against various peptides and a monoclonal antibody against choline acetyltransferase (ChAT) show that SHNs retrogradely-labeled from the hippocampus often contain ChAT, less frequently galanin-like immunoreactivity and in a few cases enkephalin, luteinizing hormone-releasing hormone, or calcitonin gene-related peptide. In contrast, cholecystokinin, vasoactive intestinal peptide, substance P, somatostatin, dynorphin-B and neurotensin, although present in some medial septal neurons, were never observed in neurons projecting to the hippocampus.

Preoptic injection of VIP, but not of secretin or PHI, inhibits LH and stimulates prolactin secretion in the ovariectomized rat

The microinjection of vasoactive intestinal peptide (VIP) into the medial preoptic area rapidly inhibited pulsatile luteinizing hormone (LH) secretion within 1 h in ovariectomized rats. A transient but significant increase in prolactin (PRL) secretion occurred after VIP injection coincidentally with the initiation of the inhibition of LH pulses. Preoptic microinjections of secretin or peptide histidine isoleucine amide (PHI) did not have such effects. These results suggest specific actions of VIP, despite its structural similarity to secretin and PHI, on the preoptic mechanisms governing LH and PRL secretion in ovariectomized rats.

The depressor effect of secretin administered either centrally or peripherally in conscious rats

The role of secretin in systemic blood pressure was examined in conscious rats. Either i.c.v. (0.5 or 1.0 micrograms/2 microliter 0.9% saline) or i.v. (1.0 or 2.0 micrograms/10 or 25 microliter saline) administration of secretin in conscious rats resulted in a significant fall in blood pressure. In consideration of previous findings that many other peptides such as substance P, enkephalin, bradykinin, neurotensin and vasoactive intestinal polypeptide cause pressor effects when administered centrally, but produce depressor responses after peripheral administration, the hypotension induced as both central and peripheral effects of secretin is unique and significant.

Effects of preoptic injections of gastrin, cholecystokinin, secretin, vasoactive intestinal peptide and PHI on the secretion of luteinizing hormone and prolactin in ovariectomized estrogen-primed rats

The effects of intracerebral injections of brain-gut peptides in the preoptic region on the secretion of luteinizing hormone (LH) and prolactin (PRL) were examined in ovariectomized, estrogen-primed rats. Gastrin or cholecystokinin-octapeptide injection in the preoptic region induced a moderate increase of circadian rise of LH secretion in some animals but no appreciable change in PRL secretion. Secretin injection was strikingly effective in increasing circadian rise of LH and PRL secretion. Vasoactive intestinal peptide injection completely abolished the occurrence of circadian rise of LH secretion whereas PHI injection facilitated LH secretion undergoing the circadian rhythm. The results suggest that those peptides act as neurotransmitters or neuromodulators in the preoptic region and are implicated in the regulation of LH and PRL secretion.